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PURPOSE. Cultured human corneal endothelial cells (HCECs) are anticipated to serve as an
alternative to donor corneas for the treatment of corneal endothelial dysfunction. However,
corneal endothelial cells (CECs) tend to exhibit fibroblastic transformation, thereby losing
their functional phenotype when cultured. The purpose of this study was to investigate the
usefulness of surface markers of CECs displaying fibroblastic phenotypes as a means of cell
characterization.
METHODS. The expression levels of 242 cell surface antigens were screened in cultured human
and monkey CECs using flow cytometry. An expression intensity ratio of nonfibroblastic/
fibroblastic CECs > 2 and of fibroblastic/nonfibroblastic CECs > 2 were selected as indicating
nonfibroblastic and fibroblastic markers, respectively. Nonfibroblastic and fibroblastic CECs
were mixed, and CD73-positive and -negative cells were sorted using flow cytometry and
further cultured. The functional phenotype of the sorted cells was evaluated according to
morphology and the expression of function-related (Naþ/Kþ-ATPase and ZO-1) and
fibroblastic (type I collagen and fibronectin) markers.
RESULTS. Flow cytometry analysis demonstrated that CD98, CD166, and CD340 are elevated in
HCECs of nonfibroblastic phenotype, while CD9, CD49e, CD44, and CD73 are markers of
fibroblastic phenotype HCECs. The CECs that sorted as CD73-negative exhibited normal
hexagonal morphology and expressed functional markers, whereas CECs that sorted as CD73-
positive exhibited the fibroblastic phenotype.
CONCLUSIONS. These markers will be useful for quality control to characterize the phenotype of
cells destined for tissue engineering-based therapy. In addition, this selection protocol will
provide a novel method for purification of functional cells.
Keywords: corneal endothelial cells, cell surface marker, tissue engineering, regenerative
medicine
The corneal endothelium regulates the aqueous humor flowto the corneal stroma through a combination of pumps and
a leaky barrier function, thereby maintaining corneal transpar-
ency.1 Corneal endothelial cells (CECs) have severely limited
proliferative ability,2,3 so healing of wounds to the corneal
endothelium is mainly performed by cell migration and
spreading. Consequently, severe damage to the corneal
endothelium resulting from pathologic conditions, such as
Fuchs’ corneal endothelial dystrophy, surgical stress, or
endotheliitis, leads to corneal endothelial dysfunction, and
ultimately to the loss of corneal transparency.4–6 Corneal
transplantation is the only therapeutic choice for treating
corneal endothelial dysfunction, but this procedure is fraught
with several associated problems, including a worldwide
shortage of donor corneas and the technical difficulty of the
surgical procedure itself, especially for patients with aphakia,
postfiltration surgery, and post-tube surgery for glaucoma.5,7
Tissue engineering presently is viewed as a potential
protocol that may overcome these problems and provide
alternative treatments for corneal endothelial dysfunction.5,8
Indeed, transplantation of cultured corneal endothelium as a
form of sheet, with or without carrier, has enabled the recovery
of corneal transparency in animal models.9–12 However,
cultured corneal endothelial sheets, as cell monolayers, are
highly fragile, making transplantation into the anterior chamber
technically difficult. Consequently, researchers, including our
group, are investigating the possibility of transplantation of
cultured cells in the form of a cell suspension.13–16 For
instance, we reported that injection of cultured CECs, in
combination with a Rho kinase (ROCK) inhibitor, enables
regeneration of the corneal endothelium in rabbit and monkey
models.16
Cultured human CECs (HCECs) have been anticipated as an
alternative tissue source to donor corneas, but the in vitro
expansion of HCECs is a bottleneck that currently limits
therapy based on tissue engineering. The technical obstacles to
cell cultivation arise from a number of features distinct to
HCECs; namely, their limited proliferative ability and tendency
to undergo spontaneous fibroblastic changes under culture
conditions. These obstacles have persisted despite attempts to
develop culture methods specifically for clinical use.17–21
We previously reported the usefulness of a ROCK inhibitor
in enhancing cell proliferation through activation of the PI3
kinase/Akt signaling pathway.17,22 The use of a conditioned
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medium obtained from GMP-grade human bone marrow–
derived mesenchymal stem cells (MSCs) also can potentiate
HCEC proliferation.20 We investigated methods to circumvent
fibroblast formation by studying the fibrosis-related signaling
pathways and found that activation of the TGF-b signaling
pathway has an important role in fibroblastic differentiation.
This finding led to the development of a culture protocol for
clinical application using SB431542 to inactivate TGF-b
signaling, which suppressed fibroblastic changes and main-
tained functional phenotypes.21 This recent progress has
reinvigorated the investigation of protocols for culturing of
HCECs for clinical use.
In the present study, we screened the surface markers of
HCECs showing normal (nonfibroblastic) and fibroblastic
phenotypes as a quality control measure for the production
of cultured HCECs for clinical use. We demonstrated that
CD98, CD166, and CD340 are dominantly expressed in the
normal CEC phenotype, while CD9, CD44, CD49e, and CD73
are markers for fibroblasts. In addition, CECs expressing a
fibroblastic marker (e.g., CD73) showed increased expression
of epithelial mesenchymal transformation (EMT) inducer
genes, a fibroblastic phenotype based on morphological
changes, and a greater production of extracellular matrix, in
addition to the loss of the functional phenotype.
MATERIALS AND METHODS
Ethics Statement
The human tissue used in this study was handled in accordance
with the tenets set forth in the Declaration of Helsinki. Human
donor corneas were obtained from SightLife (Seattle, WA, USA).
Informed written consent for eye donation for research was
obtained from the next of kin of all deceased donors. All tissues
were recovered under the tenets of the Uniform Anatomical
Gift Act (UAGA) of the particular state in which the donor
consent was obtained and the tissue was recovered. The
monkey corneas used in this study were handled in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research. The protocols for the general welfare of
the animals from which the corneas were harvested and the
procedures for isolation of the corneas were approved by the
institutional animal care and use committee of Nissei Bilis Co.,
Ltd. (Otsu, Japan). The animals were euthanized with an
overdose of intravenous pentobarbital sodium for other
research purposes, according to the guidelines on euthanasia
of the American Veterinary Medical Association (AVMA);
corneas were harvested after confirmation of cardiopulmonary
arrest by veterinarians provided by Nissei Bilis Co., Ltd.
Cell Cultures of HCECs
Human corneas were stored at 48C in storage medium (Optisol-
GS; Chiron Vision, Irvine, CA, USA). The HCECs were cultured
according to published protocols, with some modifications.21
A total of 10 human donor corneas (>60 years old) was used
for the experiments. Briefly, the Descemet’s membranes with
the CECs were stripped from donor corneas and digested at
378C with 1 mg/mL collagenase A (Roche Applied Science,
Penzberg, Germany) for 12 hours. The HCECs obtained from a
single donor cornea were seeded in one well of a 48-well plate
coated with FNC Coating Mix (Athena Environmental Sciences,
Inc., Baltimore, MD, USA). The culture medium was prepared
according to published protocols. Briefly, basal medium was
prepared with OptiMEM-I (Life Technologies Corp., Carlsbad,
CA, USA), 8% fetal bovine serum (FBS), 5 ng/mL epidermal
growth factor (EGF; Sigma-Aldrich Corp., St. Louis, MO, USA),
20 lg/mL ascorbic acid (Sigma-Aldrich Corp.), 200 mg/L
calcium chloride (Sigma-Aldrich Corp.), 0.08% chondroitin
sulfate (Wako Pure Chemical Industries, Ltd., Osaka, Japan),
and 50 lg/mL of gentamicin. Inactivated 3T3 fibroblasts,
prepared as previously described,20 then were cultured with
basal medium for 24 hours, and the conditioned basal medium
was recovered as culture medium for the HCECs. The HCECs
were cultured using culture medium prepared as above at 378C
in a humidified atmosphere containing 5% CO2, and the culture
medium was changed every 2 days. The HCECs were passaged
at ratios of 1:2 using 0.05% Trypsin-EDTA for 5 minutes at 378C
when they reached confluence. The HCECs at passages 2
through 5 were used for all experiments.
Immortalization of HCECs Using Lentiviral
Transduction of SV40 Large T Antigen and hTERT
Genes
The HCECs exhibiting normal morphology and fibroblastic
morphology were immortalized for cell sorting experiments
using SV40 and hTERT to produce normal iHCEC and
fibroblastic iHCECs cell lines, respectively. The coding
sequences of the SV40 large T antigen and hTERT genes were
amplified through PCR and were TA-cloned into a commercial
lentiviral vector. The lentiviral vectors then were transfected to
293T cells (RCB2202; Riken Bioresource Center, Ibaraki,
Japan), along with three helper plasmids (pLP1, pLP2, and
pLP/VSVG; Life Technologies Corp.), using a commercial
transfection reagent (Fugene HD; Promega Corp., Madison,
WI, USA) for 48 hours. The supernatant of the culture medium
was harvested, centrifuged briefly, and stored in a freezer at
808C. For lentiviral transduction, the virus-containing super-
natants of both genes were added to the cultures of HCECs in
the presence of 5 lg/mL of polybrene. The immortalized cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Life Technologies Corp.) containing 10% FBS, and 1% penicillin
and streptomycin; the medium was changed every two days.
Once the immortalized cells were 80% confluent, the cells
were trypsinized with 0.05% trypsin-EDTA and passaged.
Cell Culture of Monkey CECs (MCECs)
The MCECs were cultured as described previously.12 Briefly,
the Descemet’s membrane including the MCECs was stripped
and digested at 378C for 2 hours with 1 mg/mL collagenase A.
The resulting cells were suspended in culture medium, then
seeded in 1 well of a 6-well plate coated with FNC Coating Mix.
The MCECs were cultured at 378C in a medium composed of
DMEM supplemented with 10% FBS, 50 U/mL penicillin, 50 lg/
mL streptomycin, and 2 ng/mL FGF-2 (Life Technologies Corp.)
in a humidified atmosphere containing 5% CO2. The culture
medium was changed every 2 days and MCECs were passaged
at ratios of 1:2 to 4 using 0.05% Trypsin-EDTA (Life
Technologies Corp.). Cultivated MCECs at passages 2 through
5 were used for all experiments.
Flow Cytometry
Screening of cell surface markers was conducted by assessing
the expression of markers through the Human Cell Surface
Marker Screening Panel (BD Biosciences, San Jose, CA, USA)
according to the manufacturer’s protocol. Briefly, cultured
HCECs (of normal morphology and fibroblastic morphology;
not immortalized cells) and cultured MCECs (normal morphol-
ogy and fibroblastic morphology) were detached with Accu-
tase (BD Biosciences) at 378C, washed twice with PBS, passed
through a BD Falcon 70 lm cell strainer (BD Biosciences),
incubated in OptiMEM-I with the addition of 100 units/mL
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DNase for 15 minutes at room temperature, and resuspended
with BD Pharmingen Stain Buffer (BD Biosciences) containing
5 mM EDTA. The HCECs or MCECs (1.0 3 104 cells,
respectively) were incubated with primary 242 antibodies
and isotype IgGs (BD Biosciences) at the dilution indicated by
the manufacturer’s protocol for 30 minutes on ice. The cells
were washed with BD Pharmingen Stain Buffer containing 5
mM EDTA and then incubated with AlexaFluor 647 conjugated
IgGs (1:200 dilution, BD Biosciences) for 30 minutes. The cells
were washed again with BD Pharmingen Stain Buffer
containing 5 mM EDTA and analyzed by flow cytometry using
a BD FACSCant II instrument (BD Biosciences) and CellQuest
Pro software (BD Biosciences). For cell sorting experiments,
MCECs or immortalized HCECs were washed twice with PBS
and incubated with Accumax (Innovative Cell Technologies,
San Diego, CA, USA) for 10 minutes at 378C before cell sorting.
Cells were recovered in FACS buffer composed of DMEM
without Phenol Red (Nacalai Tesque, Kyoto, Japan) þ 2% FBS,
passed through a BD Falcon 70 lm cell strainer (BD
Biosciences), and resuspended in FACS buffer. The cells then
were incubated with antibodies (CD73, 1:300; BD Pharmingen
Stain Buffer), and mouse IgG (1:62.5; Dako, Glostrup, Den-
mark) for 30 minutes at 48C, then incubated with AlexaFluor
488 conjugated IgG (1:1000 dilution; BD Biosciences) for 30
minutes at 48C. After washing three times with PBS, the cells
were resuspended in FACS buffer supplemented with 2 lg/mL
propidium iodide (Sigma-Aldrich Corp.) at a density of 5 3 106
to 1 3 107 cells/ml. The CD73-positive and -negative cells were
sorted using a BD FACSAria (BD Biosciences) and seeded at a
density of 2.5 3 105 cells on a 24-well cell culture plate for
subsequent analysis.
Immunofluorescent Staining
The MCECs and HCECs were cultured at a density of 1 3 105
cells/well in a 24-well cell culture plate coated with FNC
Coating Mix and were maintained for 3 to 4 weeks for
immunofluorescence analysis. Cells were fixed in 95% ethanol
supplemented with 5% acetic acid for 10 minutes at room
temperature and incubated for 30 minutes with 1% BSA.
Samples were incubated overnight at 48C with antibodies
against CD73 (1:300; BD Pharmingen Stain Buffer), CD166
(1:300; BD Pharmingen Stain Buffer), ZO-1 (1:300; Zymed
Laboratories, South San Francisco, CA, USA), and Naþ/Kþ-
ATPase (1:300; Upstate Biotec, Lake Placid, NY, USA). After
washing with PBS, either Alexa Fluor 488-conjugated goat anti-
mouse (Life Technologies) or Alexa Fluor 594-conjugated goat
anti-rabbit IgG (Life Technologies) was used as the secondary
antibody at a 1:1000 dilution. Nuclei were stained with DAPI
(Vector Laboratories, Burlingame, CA, USA). The cells, cultured
in a 48-well cell culture plate, were directly examined by
fluorescence microscopy (BZ-9000; Keyence, Osaka, Japan).
Semiquantitative RT-PCR
Total RNA was extracted from MCECs and HCECs using the
RNeasy Mini kit (Qiagen, Hilden, Germany), after which the
quality of the RNA preparations was measured with a Nano-
Drop spectrophotometer (Thermo Fisher Scientific, Inc.,
Waltham, MA, USA). The cDNA was synthesized using ReverTra
Ace (Toyobo, Osaka, Japan) and subjected to PCR with the
specific primers listed in Table 1. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as an internal control for
gene analysis. The PCR reactions were performed using Extaq
DNA polymerase (Takara Bio, Inc., Otsu, Japan) under the
following conditions: denaturation at 948C for 30 seconds, 33
cycles of annealing at 548C for 30 seconds, and elongation at
728C for 30 seconds. The PCR products were separated by
electrophoresis on 1.5% agarose gels, stained with ethidium
bromide, and detected under ultraviolet illumination.
Quantitative Real-Time PCR
Gene expression levels were analyzed using TaqMan real-time
PCR (Applied Biosystems, Foster City, CA, USA). Total RNA was
extracted with the RNeasy mini kit, and cDNA was synthesized
using ReverTra Ace. Taqman primers for ZO1, Hs01551861_ml;
ATP1A1, Hs00167556_ml; FN1, Hs01549976_ml; and TaqMan
predevelopment human GAPDH (Applied Biosystems) were
used. The PCR was performed using the StepOne (Applied
Biosystems) real-time PCR system. The GAPDH was used as an
internal standard.
Statistical Analysis
The statistical significance (P value) of mean values for 2-
sample comparisons was determined by the Student’s t-test.
The statistical significance for the comparison of multiple
sample sets was determined with the Dunnett’s multiple-
comparisons test. Values shown on the graphs represent the
mean 6 SE.
RESULTS
Cell Surface Markers of Normal and Fibroblastic
Morphological CECs
Primate CECs often exhibit morphological fibroblastic changes
and lose their functional phenotypes,21,23 although a cell
culture maintaining the normal phenotype sometimes is
TABLE 1. Oligonucleotide Sequences
Gene Sense Primer Antisense Primer Size, bp
CD73 50-GTTCCTGTAGTCCAGGCCTATG-30 50-ACATTTCATCCGTGTGTCTCAG-30 316
CD166 50-CCCCAGAGGAATTTTTGTTTTAC-30 50-AGCCTGATGTTATCTTTCATCCA-30 289
ZO1 50-CCAGCTTCTCGAAGAACCAC-30 50-GAACGAGGCATCATCCCTAA-30 218
ATP1A1 50-ACGGCAGTGATCTAAAGGACAT-30 50-GAAGAATCATGTCAGCAGCTTG-30 255
CDH2 50-CCAGGTCTTGAGCAGTGACA-30 50-TTCCAACCTTCACCTTGACC-30 185
COL1A1 50-ATGGATTCCAGTTCGAGTATGG-30 50-GACAGTGACGCTGTAGGTGAAG-30 242
COL4A1 50-AGCAAGGTGTTACAGGATTGGT-30 50-AGAAGGACACTGTGGGTCATCT-30 392
COL8A1 50-AGAGGGGAGAAAGGACCAATAG-30 50-CCTACTTCACCAAGGAAACCTG-30 221
SNAI1 50-ACTGCAAATACTGCAACAAGGA-30 50-TCTTGACATCTGAGTGGGTCTG-30 240
SNAI2 50-CCTGTCATACCACAACCAGAGA-30 50-CTTCATCACTAATGGGGCTTTC-30 211
ZEB1 50-TTAGTTGCTCCCTGTGCAGTTA-30 50-TGTGTGAGCTATAGGAGCCAGA-30 261
GAPDH 50-GAGTCAACGGATTTGGTCGT-30 50-TTGATTTTGGAGGGATCTCG-30 238
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observed. Representative phenotypes of primary cultured
nonfibroblastic (normal) and fibroblastic cultured HCECs are
shown (Figs. 1A, 1B). Cell surface markers for normal
morphological CECs and fibroblastic CECs were evaluated by
screening for the expression of 242 cell surface antigens by
flow cytometry. The ratio of the mean fluorescence intensity of
normal CECs and fibroblastic CECs was calculated. The
markers that showed ratios of primary cultured nonfibroblas-
tic/fibroblastic HCECs > 2 (Supplemental Table S1) and
primary cultured fibroblastic/nonfibroblastic HCECs > 2
(Supplemental Table S2) are listed. The markers conserved in
humans and monkeys are more reliable, so we further
screened cell surface markers for normal morphological
MCECs and fibroblastic MCECs (Fig. 2A), selecting markers
that showed nonfibroblastic/fibroblastic or fibroblastic/non-
fibroblastic ratios that were confirmed in MCECs as well as in
HCECs (Table 2). The protein expression of CD73, which was
used as a representative marker of fibroblastic cells, was not
observed in normal phenotype MCECs, while it was observed
at the cell membrane in fibroblastic MCECs (Fig. 2B). On the
other hand, CD166, which was used as a representative marker
of normal cells, was observed at the cell membrane of
nonfibroblastic MCECs, but not in fibroblastic MCECs. The
PCR data also indicated that CD73 was strongly expressed at
the mRNA level in fibroblastic cells, but not in normal cells,
while CD166 was expressed in normal cells, but to a lesser
extent in fibroblastic cells (Fig. 2C).
CD73 Marks Fibroblastic MCECs With the Loss of
Functional Phenotype via Epithelial Mesenchymal
Transformation
Our goal was to detect possible contamination with vulnerable
fibroblastic transformed cells, so we further investigated the
reliability of using CD73 as a potential fibroblastic marker,
since CD73 reportedly is involved in lung and liver fibrosis.24,25
Experiments were conducted to determine whether fibroblas-
tic cells could be detected by CD73 in a mixture of normal and
fibroblastic cells by mixing nonfibroblastic MCECs and
fibroblastic MCECs at 1:1 ratio (Fig. 3A) and then sorting out
the CD73-negative and -positive cells (Fig. 3B). After culturing,
the CD73-negative sorted MCECs exhibited a normal hexagonal
morphology, whereas the CD73-positive MCECs exhibited
fibroblastic morphology (Fig. 3C). The PCR analysis showed
that CD73-negative MCECs did not express CD73, while CD73-
positive MCECs expressed CD73 at the mRNA level (Fig. 3D). A
nonfibroblastic marker, CD166, was expressed in the CD73-
negative MCECs, but CD166 was expressed at a lower rate in
the CD73-positive cells (Fig. 3D). The CD73-positive cells also
expressed higher levels of COL1A1, an extracellular matrix
FIGURE 2. Expression of CD73 and CD166 in nonfibroblastic and fibroblastic MCECs. (A) The image on the left shows the MCECs of normal
phenotype, while the image on the right shows MCECs of fibroblastic phenotype. Scale bar: 100 lm. (B) The MCECs of nonfibroblastic and
fibroblastic phenotypes were immunostained with the antibodies against CD73 and CD166. The fibroblastic phenotype cells expressed CD73 at the
cell membrane, while no expression was observed in cells of normal phenotype. The CD166 was expressed at the cell membrane of normal
phenotype cells, while it was very weakly stained in fibroblastic phenotype cells. Scale bar: 100 lm. (C) The mRNA levels of CD73 and CD166 were
evaluated using PCR. Gene CD73 was expressed at higher levels in fibroblastic MCECs than in normal MCECs. On the other hand, CD166 was
expressed at higher levels in normal MCECs than in fibroblastic MCECs.
FIGURE 1. Nonfibroblastic and fibroblastic phenotypes exhibited
during primary culture of HCECs. Primary cultivated HCECs demon-
strated various phenotypes during cultivation using the same culture
protocol. Representative phenotypes are presented. (A) Nonfibroblas-
tic phenotype in which the cells maintained the characteristic
polygonal contact-inhibited shape and monolayer. (B) Fibroblastic
phenotype in which the cells were stratified and fibroblastic. Scale bar:
100 lm.
TABLE 2. Selected Markers of Nonfibroblastic and Fibroblastic CECs
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protein produced under pathologic conditions by the corneal
endothelium (Fig. 4A).26,27 On the other hand, the CD73-
positive cells showed a much lower expression of COL4A1 and
COL8A1, which normally are produced by the corneal
endothelium (Fig. 4A). The CD73-positive cells also expressed
higher levels of genes associated with induction of the
epithelial mesenchymal transformation (EMT), such as SNAI1,
SNAI2, and ZEB1 (Fig. 4B). Staining for endothelial character-
istics revealed that the staining pattern of ZO-1 and Naþ/Kþ-
ATPase at the plasma membrane was well preserved in CD73-
negative MCECs, whereas the CD73-positive MCECs lost the
characteristic staining profile of ZO-1 and Naþ/Kþ-ATPase at the
plasma membrane (Fig. 4C). The data for immunofluorescence
staining were supported by mRNA expression data for ZO1,
ATP1A1, and CDH2, which were expressed in CD73-negative
MCECs, but showed low expression in CD73-positive MCECs
(Fig. 4D).
CD73 as a Cell Surface Marker for Fibroblastic
HCECs
We also investigated whether CD73 could be used to detect the
fibroblastic forms of human as well as monkey CECs. The
primary cultured HCECs tended to undergo fibroblastic
changes when passed through a cell strainer for flow
cytometry, so we established immortalized nonfibroblastic
and fibroblastic HCECs cell lines (Fig. 5A). The same types of
experiments performed with MCECs were repeated with
immortalized HCECs and cells expressing or not expressing
CD73 were cultured (Fig. 5B). Flow cytometry analysis
demonstrated that the purity of CD73-negative sorted immor-
talized HCECs was 97.6% (Fig. 5C). The CD73-negative
immortalized HCECs again exhibited a normal hexagonal,
contact-inhibited morphology, while CD73-positive immortal-
ized HCECs exhibited a fibroblastic, stratified morphology (Fig.
5D).
Immunostaining showed that CD73 was expressed in the
CD73-positive sorted immortalized HCECs, but not in CD73-
negative sorted immortalized HCECs (even after further
cultivation, Fig. 5E). The ZO-1 and Naþ/Kþ-ATPase were
functionally expressed at the plasma membrane in CD73-
negative immortalized HCECs, while CD73-positive immortal-
ized HCECs lost this normal expression of ZO-1 and Naþ/Kþ-
ATPase (Fig. 5E). The CD73-positive sorted immortalized
HCECs expressed higher CD73 at the mRNA level than
CD73-negative sorted immortalized HCECs (Fig. 5F).
Quantitative PCR analysis showed that expression of ZO1
and ATP1A1 was significantly reduced in CD73-positive cells
compared to CD73-negative cells (Fig. 5G). On the other hand,
expression of FN1 was higher in CD73-positive cells than in
CD73-negative cells (Fig. 5G).
DISCUSSION
Extensive progress recently has raised the possibility of new
therapeutic modalities based on tissue engineering techniques
for various diseases.28,29 However, although the FDA regulates
interstate commerce in human cells and tissue-based products
(HCT/Ps),30 and although other countries also have similar
systems,31 the current regulatory frameworks are not presently
viewed as providing sufficient coverage of innovative tissue
engineering therapies.32 In the present study, we investigated
biological markers of HCECs for quality control with a view to
clinical settings where cell characterization could be ensured.
The Naþ/Kþ-ATPase and ZO-1 investigated here are used
frequently for research purposes, as coexpression of these
proteins is recognized as identifying cells that possess pump
FIGURE 3. Cell sorting of MCECs by CD73. (A, B) Cultured MCECs exhibiting nonfibroblastic and fibroblastic phenotypes were harvested from the
culture plate and mixed at 1:1 ratio. Mixed cells were stained for CD73 and were sorted by flow cytometry. Two peaks, CD73-positive and
–negative, were observed. Scale bar: 100 lm. (C) The MCECs were sorted according to the expression level of CD73 and were cultured to reach
confluence. The CD73-negative cells had a hexagonal normal morphology, while CD73-positive cells had a fibroblastic morphology. Scale bar: 100
lm. (D) The mRNA expression levels of CD73 and CD166 in sorted CD73-negative and -positive cells evaluated by PCR. The CD73-positive sorted
cells expressed CD73 at the mRNA level, while CD73-negative sorted cells expressed almost no CD73. On the other hand, CD166 mRNA was
expressed at a higher level in CD73-negative sorted cells than in CD73-positive sorted cells. These experiments were performed in triplicate.
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and barrier functional activity.33,34 However, these proteins are
not specific to corneal endothelium and are expressed in other
organs, such as the heart, kidneys, and brain.35–38 The genes
that are known to have a role in corneal endothelium, such as
SLC4A (Na, HCO3 co-transporter), COL4A2 (type IV collagen),
COL8A2 (type VIII collagen), and CDH2 (N-cadherin), also
have been used as markers.39 However, no single specific gene
was identified as an HCEC marker,40 even though gene
expression profiles were reported in donor corneal endothe-
lium.41,42
Recently, Glypican-4 and CD200 were proposed as HCEC
markers to distinguish HCECs from corneal stromal fibroblasts,
based on RNA sequencing and immunofluorescence staining.43
However, the practical problem of HCEC culture is the
potential contamination with vulnerable transformed HCECs,21
so the purity of the cultured HCECs destined for clinical use
must first be ensured. The lack of a specific marker led us to
screen surface antigens that could be used to identify whether
cultured cells retain their functional phenotype or have
undergone fibroblastic changes. Further studies are required
to determine which marker or combination of markers will be
most appropriate for quality control, but assessment of
markers using flow cytometry will provide us with a
quantitative threshold by which to ensure the functional
characteristics for clinical application.
The results of the current study also pointed to the novel
possibility of an in vitro cell expansion protocol, whereby
purified HCECs can be separated from a general culture cell
population possibly contaminated with transformed HCECs
simply by using the positive and negative cell selection that is
readily accomplished by FACS. Recent developments have
enabled the inhibition of fibroblastic changes and greater
success rates for cell culture,21 but a cell selection technique
still would be anticipated to ultimately circumvent potential
contamination by fibroblastic cells.43 Peh GS et al.44 reported
the separation of prefluorescein-labeled corneal stromal
fibroblasts from a mixture of fibroblasts and HCECs by
magnetic affinity cell separation (MACS) and suggested that
this type of selection strategy would be useful for depleting the
cultures of contaminating cells. To the best of our knowledge,
ours is the first report showing this depletion of fibroblastic
cells and purification of normal phenotype CECs from a mixed
FIGURE 4. Functional analysis of CD73-positive MCECs. (A) Expressions of COL1A1 (pathologic collagen of corneal endothelium), COL4A1 (normal
collagen), and COL8A1 (normal collagen) in CD73-negative and -positive sorted cells were evaluated using PCR. Greater expression of COL1A1 was
seen in CD73-positive cells than in CD73-negative cells. Greater expression of COL4A1 and COL8A1 was found in CD73-negative sorted cells than in
CD73-positive cells. (B) Expression of EMT inducer genes (SNAI1, SNAI2, and ZEB1) was evaluated by PCR. The CD73-positive sorted cells showed
greater expression of SNAI1, SNAI2, and ZEB1 when compared to CD73-negative cells. (C) Immunofluorescence staining of CD73-negative or -
positive sorted cells by ZO-1 and Naþ/Kþ-ATPase. Both ZO-1 and Naþ/Kþ-ATPase were stained at the plasma membrane of CD73-negative cells.
However, their expression was disrupted and decreased in CD73-positive cells. Scale bar: 50 lm. (D) Expression levels of ZO1, ATP1A1, and CDH2
were evaluated using PCR. The CD73-negative cells expressed ZO1, ATP1A1, and CDH2 at the mRNA level, while their expression was decreased in
CD73-positive cells. These experiments were performed in triplicate.
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FIGURE 5. Cell sorting of immortalized HCECs and functional analysis of CD73-positive immortalized HCECs. (A) Normal hexagonal contact-
inhibited phenotype HCECs and fibroblastic HCECs were immortalized using SV40 and hTERT to establish cell lines. (B) Immortalized normal
HCECs and fibroblastic HCECs were harvested from culture plates and mixed. The CD73-negative and -positive cells then were sorted by flow
cytometry. (C) The CD73-negative and -positive immortalized HCECs were sorted and CD73 expression was analyzed using flow cytometry. A total
of 96.7% of CD73-negative sorted cells expressed CD73, while 97.6% of CD73-positive sorted cells did not express CD73. (D) The CD73-negative
and -positive sorted immortalized HCECs were seeded and cultured until confluent. The CD73-negative cells showed hexagonal morphology, while
CD73 (þ) and unsorted control cells showed fibroblastic morphology. (E) Immunofluorescence staining of CD73, ZO-1, and Naþ/Kþ-ATPase. The
Functional Phenotypic Corneal Endothelial Cell IOVS j November 2014 j Vol. 55 j No. 11 j 7616
Downloaded from iovs.arvojournals.org on 06/29/2019
cell population using FACS. Although we successfully separat-
ed fibroblastic cells from the immortalized HCEC-population by
FACS, primary cultured HCECs tended to exhibit fibroblastic
changes after cell sorting by our current protocol, due to
complete cell dissociation for FACS (data not shown). Thus, the
details of this selection procedure, especially for human cells,
should be optimized; for example, through the use of
antifibroblastic molecule during cell dissociation21 and the
separation by MACS rather than FACS.44 These results suggest
that the depletion of fibroblastic cells based on cell surface
antigens should be explored further to isolate a purified cell
population for clinical use.
We considered that detection of fibroblastic cell contami-
nation would be possible if we could discover a marker for
fibroblastic HCECs. Indeed, CD73 enabled the detection of
fibroblastic cells, and further separation of normal and
fibroblastic cells. The CD73 (ecto-50-nucleotidase) is mem-
brane-bound glycoprotein that metabolizes adenosine 5 0-
monophostate (AMP) to adenosine.45 Expression of CD73 is
observed in a variety of cell types and regulates various
physiological phenomena, such as ion and fluid transport,
barrier function, adaptation to hypoxia, and inflammation.45
Little is known regarding the involvement of CD73 in
fibroblastic transformation, but this glycoprotein has an
important role in bleomycin-induced lung injury24 and hepatic
fibrosis25 through the conversion of AMP to adenosine. In the
corneal endothelium, we showed that EMT inducer genes,
such as SNAI1, SNAI2, and ZEB1, were activated in CD73-
positive cells,21 which suggests that the EMT might be involved
in the elevated expression of CD73.
In conclusion, we demonstrated that CD98, CD166, and
CD340 could serve as markers of the nonfibroblastic pheno-
type of HCECs, and that CD9, CD44, CD49e, and CD73 could
serve as markers of the fibroblastic phenotype of these cells.
These markers could be used for quality control to characterize
the cellular phenotype used in therapies based on tissue
engineering, though the threshold for clinical use should be
explored further. Further, if positive and negative cell selection
proves applicable to clinical settings, cell sorting based on
these cell surface markers will provide a novel strategy for
purifying functional cells.
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